BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $13.2 million in its second quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of 6 cents. Losses, adjusted for non-recurring gains, came to 52 cents per share.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $425.5 million in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $389.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
